From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use

To develop guidance for women at high risk of HIV, WHO carefully considered the risks of maternal morbidity and mortality from unintended pregnancy against possible increased risk of HIV acquisition with injectable use. Among the many challenges: (1) balancing timeliness of changing the guidance aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Leo, Patil, Eva, Kidula, Nancy, Lyn Gaffield, Mary, Steyn, Petrus S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752602/
https://www.ncbi.nlm.nih.gov/pubmed/29284693
http://dx.doi.org/10.9745/GHSP-D-17-00278
_version_ 1783290135290314752
author Han, Leo
Patil, Eva
Kidula, Nancy
Lyn Gaffield, Mary
Steyn, Petrus S.
author_facet Han, Leo
Patil, Eva
Kidula, Nancy
Lyn Gaffield, Mary
Steyn, Petrus S.
author_sort Han, Leo
collection PubMed
description To develop guidance for women at high risk of HIV, WHO carefully considered the risks of maternal morbidity and mortality from unintended pregnancy against possible increased risk of HIV acquisition with injectable use. Among the many challenges: (1) balancing timeliness of changing the guidance against the potential impact of it; (2) engaging a range of stakeholders; (3) translating complex research and policy messages to clients; (4) needing additional research; and (5) monitoring and evaluating successes and challenges with implementing new guidelines.
format Online
Article
Text
id pubmed-5752602
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-57526022018-01-10 From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use Han, Leo Patil, Eva Kidula, Nancy Lyn Gaffield, Mary Steyn, Petrus S. Glob Health Sci Pract Commentary To develop guidance for women at high risk of HIV, WHO carefully considered the risks of maternal morbidity and mortality from unintended pregnancy against possible increased risk of HIV acquisition with injectable use. Among the many challenges: (1) balancing timeliness of changing the guidance against the potential impact of it; (2) engaging a range of stakeholders; (3) translating complex research and policy messages to clients; (4) needing additional research; and (5) monitoring and evaluating successes and challenges with implementing new guidelines. Global Health: Science and Practice 2017-12-28 /pmc/articles/PMC5752602/ /pubmed/29284693 http://dx.doi.org/10.9745/GHSP-D-17-00278 Text en © Han et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-17-00278
spellingShingle Commentary
Han, Leo
Patil, Eva
Kidula, Nancy
Lyn Gaffield, Mary
Steyn, Petrus S.
From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
title From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
title_full From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
title_fullStr From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
title_full_unstemmed From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
title_short From Research to Policy: The WHO Experience With Developing Guidelines on the Potential Risk of HIV Acquisition and Progestogen-Only Contraception Use
title_sort from research to policy: the who experience with developing guidelines on the potential risk of hiv acquisition and progestogen-only contraception use
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752602/
https://www.ncbi.nlm.nih.gov/pubmed/29284693
http://dx.doi.org/10.9745/GHSP-D-17-00278
work_keys_str_mv AT hanleo fromresearchtopolicythewhoexperiencewithdevelopingguidelinesonthepotentialriskofhivacquisitionandprogestogenonlycontraceptionuse
AT patileva fromresearchtopolicythewhoexperiencewithdevelopingguidelinesonthepotentialriskofhivacquisitionandprogestogenonlycontraceptionuse
AT kidulanancy fromresearchtopolicythewhoexperiencewithdevelopingguidelinesonthepotentialriskofhivacquisitionandprogestogenonlycontraceptionuse
AT lyngaffieldmary fromresearchtopolicythewhoexperiencewithdevelopingguidelinesonthepotentialriskofhivacquisitionandprogestogenonlycontraceptionuse
AT steynpetruss fromresearchtopolicythewhoexperiencewithdevelopingguidelinesonthepotentialriskofhivacquisitionandprogestogenonlycontraceptionuse

Ejemplares similares